| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |